Elanco Animal Health Cash Flow from Financial Activities 2016-2024 | ELAN
Elanco Animal Health annual/quarterly cash flow from financial activities history and growth rate from 2016 to 2024. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
- Elanco Animal Health cash flow from financial activities for the quarter ending December 31, 2024 was $-1.492B, a 1697.59% increase year-over-year.
- Elanco Animal Health cash flow from financial activities for the twelve months ending December 31, 2024 was $-3.099B, a 960.83% decline year-over-year.
- Elanco Animal Health annual cash flow from financial activities for 2024 was $-1.492B, a 1697.59% increase from 2023.
- Elanco Animal Health annual cash flow from financial activities for 2023 was $-0.083B, a 84.88% decline from 2022.
- Elanco Animal Health annual cash flow from financial activities for 2022 was $-0.549B, a 361.43% decline from 2021.
| Elanco Animal Health Annual Cash Flow Financial (Millions of US $) |
|
|---|---|
| 2024 | $-1,492 |
| 2023 | $-83 |
| 2022 | $-549 |
| 2021 | $210 |
| 2020 | $4,954 |
| 2019 | $-305 |
| 2018 | $-35 |
| 2017 | $848 |
| 2016 | $-150 |
| 2015 | $5,353 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $6.417B | $4.439B |
| Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $19.868B | 19.58 |
| Encompass Health (EHC) | United States | $12.183B | 25.83 |
| DaVita (DVA) | United States | $10.978B | 15.44 |
| Chemed (CHE) | United States | $8.483B | 26.66 |
| Option Care Health (OPCH) | United States | $5.441B | 24.26 |
| RadNet (RDNT) | United States | $4.587B | 291.14 |
| Amedisys (AMED) | United States | $3.105B | 20.89 |
| LifeStance Health (LFST) | United States | $2.271B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.054B | 22.55 |
| Astrana Health (ASTH) | United States | $1.524B | 37.75 |
| U.S Physical Therapy (USPH) | United States | $1.213B | 31.31 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.169B | 66.56 |
| Pennant (PNTG) | United States | $1.042B | 38.25 |
| Atai Life Sciences (ATAI) | Germany | $0.331B | 0.00 |
| Daxor (DXR) | United States | $0.037B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Ontrak (OTRK) | United States | $0.007B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |